NTLA announcements Intellia Therapeutics, Inc. announcements and dividends declared NASDAQ

Intellia Therapeutics, Inc. Complete list of announcements declared & dividend announcements by Intellia Therapeutics, Inc. NTLA

Intellia Therapeutics, Inc. NTLA listed on NASDAQ and deals in Health Care Biotechnology In Vitro In Vivo Diagnostic Substances

Announcements and dividends declared by Intellia Therapeutics, Inc. NTLA

Why Intellia Therapeutics, Inc. (NTLA) Outpaced the Stock Market Today
The most recent trading session ended with Intellia Therapeutics, Inc. (NTLA) standing at .60, reflecting a +1.42% shift from the previouse trading day's closing. This change outpaced the S&P 500's 1.26% gain on the day. On
Announcement as on 03 May 2024

: Intellia Therapeutics stock gains on CRISPR treatment results
Intellia Therapeutics Inc. NTLA shares gained 6.4% premarket on Monday after the clinical stage genome-editing company announced new data from a trial of an investigational CRISPR-based therapy for hereditary angioedema. Patients treated with a single dose
Announcement as on 12 June 2023

Bernstein Initiates Coverage of Intellia Therapeutics (NTLA) with Outperform Recommendation
On March 21, 2023, Bernstein initiated coverage of Intellia Therapeutics with a Outperform recommendation.
Announcement as on 21 March 2023

BMO Capital Upgrades Intellia Therapeutics (NTLA)
On March 14, 2023, BMO Capital upgraded their outlook for Intellia Therapeutics (NASDAQ:NTLA) from Market Perform to Outperform.
Announcement as on 15 March 2023

Will Intellia Therapeutics Stock Rebound After A 31% Fall In A Month?
Intellia Therapeutic’s stock (NASDAQ: NTLA), a biotechnology company developing treatments using the CRISPR gene-editing system, has seen a fall of 31% in a month, while it’s down 69% this year. This compares with -2% and -18% returns for
Announcement as on 20 December 2022

Announcements by Intellia Therapeutics, Inc. first page | Next page |

NTLA Intellia Therapeutics, Inc. current price & indicator signals

Moving Averages for Intellia Therapeutics, Inc.

  • 5Day Average: 24.82
  • 12Day Average: 25.35
  • 20Day Average: 24.52
  • 50Day Average: 24.49
  • 100Day Average: 26.17
  • 150Day Average: 27.11
  • 200Day Average: 28.63

NTLA Indicators & signals

Indicator MACD (12,26,9)

24.77, 24.54, 0.32
Indicator MACD is in positive zone

Indicator ADX (14)

13.79, 19.53, 25.78
Indicator ADX is indicating that momentum is weak.
Momentum is towards selling.

Indicator RSI (14)

Current RSI is: 48
Indicator RSI is indicating buying momentum and stock might rise.

Recent prices of NTLA Intellia Therapeutics, Inc. are as follows: Daily volume is divided by 10 day averaged volume

Date Close Range Change % Volume
28 Tue May 2024 22.72 22.64 to 25.25 -8.53% 1.68 times
24 Fri May 2024 24.84 24.61 to 25.17 -0.16% 0.69 times
23 Thu May 2024 24.88 24.68 to 25.97 -4.2% 1.19 times
22 Wed May 2024 25.97 25.20 to 26.46 1.01% 0.92 times
21 Tue May 2024 25.71 25.51 to 26.40 -0.7% 0.95 times
20 Mon May 2024 25.89 25.72 to 26.41 -1.26% 0.81 times
17 Fri May 2024 26.22 25.81 to 26.55 0.19% 0.9 times
16 Thu May 2024 26.17 25.82 to 26.46 -0.19% 1.02 times
15 Wed May 2024 26.22 25.99 to 27.17 1.9% 1.11 times
14 Tue May 2024 25.73 25.60 to 26.98 1.22% 0.99 times
13 Mon May 2024 25.42 24.93 to 26.74 3.92% 1.41 times
10 Fri May 2024 24.46 24.22 to 25.42 -1.61% 1.7 times

Videos related to: NTLA announcements Intellia Therapeutics, Inc. announcements and dividends declared NASDAQ

Videos related to: NTLA announcements Intellia Therapeutics, Inc. announcements and dividends declared NASDAQ

Hindi Video Correct Way Of Fundamental Analysis Using EPS And PE - MunafaSutra

Hindi Video What Is Needed To Succeed In Stock Markets

NTLA announcements Intellia Therapeutics, Inc. announcements and dividends declared NASDAQ

 

Back to top